330 related articles for article (PubMed ID: 24075941)
21. MASTL promotes cell contractility and motility through kinase-independent signaling.
Taskinen ME; Närvä E; Conway JRW; Hinojosa LS; Lilla S; Mai A; De Franceschi N; Elo LL; Grosse R; Zanivan S; Norman JC; Ivaska J
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32311005
[TBL] [Abstract][Full Text] [Related]
22. betaPak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth.
Shin EY; Lee CS; Cho TG; Kim YG; Song S; Juhnn YS; Park SC; Manser E; Kim EG
J Biol Chem; 2006 Nov; 281(47):35954-64. PubMed ID: 16954223
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.
Cho HJ; Liu G; Jin SM; Parisiadou L; Xie C; Yu J; Sun L; Ma B; Ding J; Vancraenenbroeck R; Lobbestael E; Baekelandt V; Taymans JM; He P; Troncoso JC; Shen Y; Cai H
Hum Mol Genet; 2013 Feb; 22(3):608-20. PubMed ID: 23125283
[TBL] [Abstract][Full Text] [Related]
24. Non-muscle myosin II regulates neuronal actin dynamics by interacting with guanine nucleotide exchange factors.
Shin EY; Lee CS; Yun CY; Won SY; Kim HK; Lee YH; Kwak SJ; Kim EG
PLoS One; 2014; 9(4):e95212. PubMed ID: 24752242
[TBL] [Abstract][Full Text] [Related]
25. Golgi-resident TRIO regulates membrane trafficking during neurite outgrowth.
Tao T; Sun J; Peng Y; Li Y; Wang P; Chen X; Zhao W; Zheng YY; Wei L; Wang W; Zhou Y; Liu J; Shi YS; Zhu MS
J Biol Chem; 2019 Jul; 294(28):10954-10968. PubMed ID: 31152060
[TBL] [Abstract][Full Text] [Related]
26. Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX.
Filipenko NR; Attwell S; Roskelley C; Dedhar S
Oncogene; 2005 Sep; 24(38):5837-49. PubMed ID: 15897874
[TBL] [Abstract][Full Text] [Related]
27. Solo/Trio8, a membrane-associated short isoform of Trio, modulates endosome dynamics and neurite elongation.
Sun YJ; Nishikawa K; Yuda H; Wang YL; Osaka H; Fukazawa N; Naito A; Kudo Y; Wada K; Aoki S
Mol Cell Biol; 2006 Sep; 26(18):6923-35. PubMed ID: 16943433
[TBL] [Abstract][Full Text] [Related]
28. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease.
Elliott DA; Kim WS; Gorissen S; Halliday GM; Kwok JB
Mov Disord; 2012 Jul; 27(8):1004-11. PubMed ID: 22528366
[TBL] [Abstract][Full Text] [Related]
29. Enhanced dendritogenesis and axogenesis in hippocampal neuroblasts of LRRK2 knockout mice.
Paus M; Kohl Z; Ben Abdallah NM; Galter D; Gillardon F; Winkler J
Brain Res; 2013 Feb; 1497():85-100. PubMed ID: 23270607
[TBL] [Abstract][Full Text] [Related]
30. Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations.
Sheng Z; Zhang S; Bustos D; Kleinheinz T; Le Pichon CE; Dominguez SL; Solanoy HO; Drummond J; Zhang X; Ding X; Cai F; Song Q; Li X; Yue Z; van der Brug MP; Burdick DJ; Gunzner-Toste J; Chen H; Liu X; Estrada AA; Sweeney ZK; Scearce-Levie K; Moffat JG; Kirkpatrick DS; Zhu H
Sci Transl Med; 2012 Dec; 4(164):164ra161. PubMed ID: 23241745
[TBL] [Abstract][Full Text] [Related]
31. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
Niu J; Yu M; Wang C; Xu Z
J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
[TBL] [Abstract][Full Text] [Related]
32. Leucine-rich repeat kinase 2 modulates retinoic acid-induced neuronal differentiation of murine embryonic stem cells.
Schulz C; Paus M; Frey K; Schmid R; Kohl Z; Mennerich D; Winkler J; Gillardon F
PLoS One; 2011; 6(6):e20820. PubMed ID: 21695257
[TBL] [Abstract][Full Text] [Related]
33. Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation.
Han KA; Shin WH; Jung S; Seol W; Seo H; Ko C; Chung KC
Hum Mol Genet; 2017 Jan; 26(1):1-18. PubMed ID: 27798112
[TBL] [Abstract][Full Text] [Related]
34. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models.
Li T; Yang D; Zhong S; Thomas JM; Xue F; Liu J; Kong L; Voulalas P; Hassan HE; Park JS; MacKerell AD; Smith WW
Hum Mol Genet; 2014 Dec; 23(23):6212-22. PubMed ID: 24993787
[TBL] [Abstract][Full Text] [Related]
35. The familial Parkinsonism gene LRRK2 regulates neurite process morphology.
MacLeod D; Dowman J; Hammond R; Leete T; Inoue K; Abeliovich A
Neuron; 2006 Nov; 52(4):587-93. PubMed ID: 17114044
[TBL] [Abstract][Full Text] [Related]
36. Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain.
Higashi S; Moore DJ; Colebrooke RE; Biskup S; Dawson VL; Arai H; Dawson TM; Emson PC
J Neurochem; 2007 Jan; 100(2):368-81. PubMed ID: 17101029
[TBL] [Abstract][Full Text] [Related]
37. Anatomical localization of leucine-rich repeat kinase 2 in mouse brain.
Melrose H; Lincoln S; Tyndall G; Dickson D; Farrer M
Neuroscience; 2006; 139(3):791-4. PubMed ID: 16504409
[TBL] [Abstract][Full Text] [Related]
38. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?
Gillardon F
J Neurochem; 2009 Sep; 110(5):1514-22. PubMed ID: 19545277
[TBL] [Abstract][Full Text] [Related]
39. A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation.
Law BM; Spain VA; Leinster VH; Chia R; Beilina A; Cho HJ; Taymans JM; Urban MK; Sancho RM; Blanca Ramírez M; Biskup S; Baekelandt V; Cai H; Cookson MR; Berwick DC; Harvey K
J Biol Chem; 2014 Jan; 289(2):895-908. PubMed ID: 24275654
[TBL] [Abstract][Full Text] [Related]
40. Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics.
Bardai FH; Ordonez DG; Bailey RM; Hamm M; Lewis J; Feany MB
PLoS Biol; 2018 Dec; 16(12):e2006265. PubMed ID: 30571694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
